Statins affect human glioblastoma and other cancers through TGF-β inhibition

SUPPLEMENTARY METHODS
Soft agar colony formation
A total of 5×10 3 GBM cells or G34 cells per well were seeded in a 48-well plate in 0.3 ml of 0.4% agar medium over 0.5 ml of 0.8% agar Phosphate-buffered saline (PBS). Medium (1 ml) was added after plating the top agar for one hour. Simvastatin was added to the top agar and medium with or without TGF-β2 at the desired concentration. After 28 days, media were carefully removed and 0.5ml of 0.005% crystal violet was added overnight. Photomicrographs of colonies were taken at 50x magnification. The number of colonies was determined with ImagePro 4.5.
High-throughput screening of a natural product library for targeting a mesenchymal GIC line (Supplementary Figure 2 experiment):
Mesenchymal GBM cell line GBM1123 was cultured in DMEM/F12 with 1% penicillin-streptomycin, GlutaMAX (1X), B27 (1X), heparin (5μg/ml), bFGF (20ng/ml) and EGF (50ng/ml) for sphere culture or DMEM/F12 with 10% serum and 1% penicillinstreptomycin for adherent culture. GBM1123 neurospheres were seeded in a 384-well plate at 1.0 × 10 3 cells/well) in serum-free media and incubated for 72h. Screening samples composed of 28,160 microbial metabolites (Technology Research Association for Next generation natural products chemistry) were added to neurospheres at a concentration of 0.5% and incubated for another 72h. Neurospheres were then stained with 1μg/ml propidium iodide (PI) and 1μg/ml Hoechst33342 (Dojindo) for 1h. Fluorescent images were observed using IN Cell Analyzer 6000 (GE Healthcare) or Opera Phenix (PerkinElmer).
Adherent cultures of GBM1123 in serum media were seeded at 1.0 × 10 3 cells/well in 384-well microplates (Greiner) and incubated for 4h. The same screening samples (0.5%) were added and incubated for 72h. Cell viabilities were measured using WST-8-based Cell Counting Kit8 (Dojindo) and Envision multilabel plate reader (PerkinElmer). Statins from US-Drug Collection (MicroSource) and Chemical library (Prestwick) were used for secondary evaluation.
Immunohistochemical staining of simvastatin-or control-treated brains with GBMs for Iba1 to indicate macrophages/microglia
The tissue sections were deparaffinized, dehydrated, antigen unmasked, and blocked. Then rabbit anti-mouse Iba 1 primary antibody (Invitrogen, 1:500) was applied and incubated at 4°C overnight. Biotinylated donkey antirabbit (Jackson ImmunoResearch Laboratories) antibody was used as secondary antibody. After incubation with an avidin-biotin complex (VECTOR LABORATORIES, INC.) at room temperature for 30 mins, immunoreactivity was visualized by incubating the sections with 3, 3-diaminobenzidine tetrahydrochloride (Dako Corp) to produce a brown precipitate and then counterstained with hematoxylin. Photos were taken with a Nikon microscope equipped with a CCD camera.
Iba1 immunostainings were quantified using the Image J program. Color threshold was selected within the image/adjust menu. An appropriate color threshold (RGB) was chosen (Red: 0-103, Green: 0-104, Blue: 0-69) to include the staining of signal (Iba1 + ). The area outside of tumor was manually selected. Under the Analyze menu, Measure was selected for obtaining the number within the selected area. Within the Analyze/Analyze particle menu, Size was set from 0.01 to infinity, Show was selected to Masks to ensure non-specific staining was excluded and Summarize was selected to obtain the count of staining cells and %Area (total area with signal divide by selected outside of tumor area). %Area and normalized count of staining cells (count of staining cells divided by selected area) from each group were then used for statistical analysis. 
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